AKT1 and hepatocellular carcinoma: Moreover, NEAT1 induced sorafenib resistance in HCC cells by activating the c-MET/AKT pathway via microRNA (miR)-335 [20] or promoting autophagy via the miR-204/autophagy-related 3 axis [21].